Nordic-Baltic HTA Forum – what’s happening nationally, regionally and in EU?

  How does Health Technology Assessments (HTA) work in each of the Nordic-Baltic countries? What collaboration exists between countries and authorities today? Get the latest updates regarding EU vs Regional vs National level decisions and ongoing initiatives. Learn from each other, meet and discuss across organizational and country borders. Meet representatives from the Authorities and Industry and expand your network and knowledge within the Nordic-Baltic region within the field of Health Technology Assessments. Welcome to your new forum!  

Who should attend?

Professionals from Health Technology and Regulatory Authorities, pharma industry, consultants, health care, payers, patient organisations and academia. You who are working with or interested in Health Technology Assessments in the Nordic-Baltic region.

Program at a quick glance!

• Update from EU commission on the new HTA regulation
• How does HTA work in each of the Nordic-Baltic countries?
• EU framework now and in the future
• Existing cross-country collaborations with focus on Nordic/Baltics
• Panel: How to generate real-world data to support HTA?
• Workshop
• Networking
• See detailed program here

  Confirmed speakers and moderators

  Anna-Eva Ampelas, European Commission Niklas Hedberg, The Dental and Pharmaceutical Benefits Agency (Sweden), EUnetHTA Sofie Gustafsson, The Dental and Pharmaceutical Benefits Agency (Sweden) Trine Ann Behnk, Amgros I/S (Denmark) Cecilie Astrup Frederiksen, Amgros I/S (Denmark) Antra Fogele, State Agency of Medicines (Latvia) Tomas Lasys, previously at State Medicines Control Agency (Lithuania) Kristina Garuoliene, Vilnius University (Lithuania) Ott Laius, State Agency of Medicines (Estonia) Piia Rannanheimo, Finnish Medicines Agency (Finland) Einar Andreassen, The Norwegian Medicines Agency (Norway) Dag Larsson, Lif, the research-based pharmaceutical industry (Sweden) Jonas Vikman, Lif, the research-based pharmaceutical industry (Sweden) Björn Wettermark, Uppsala University (Sweden) Ólöf Þórhallsdóttir, Icelandic Medicines Agency (Iceland)

  Time and venue

  The forum is held online in Zoom on December 8. It starts at 8:30 AM CET with login and welcome interactions and ends preliminary at 3:30 PM CET. For forum documentation and networking we will use a digital platform called Howspace. You will get access to Howspace before the online forum begins.

  Participation fee

  The registration fee is 3.900 SEK until November 22 and thereafter 5.400 SEK. The fee includes digital documentation, certificate in digital format. All prices excludes VAT. Get 20% off for group registration of 5 participants or more. Use the following discount code at the registration form 14377group  Students/Academic researchers 50% off participation fee. Simply add comment student or Academic researcher and your university in comments section when registering. Regarding cancellation policy and GDPR - please see "Registration Terms" to the right

  Warm welcome from the Program Committée

  Björn Wettermark, Uppsala University Dag Larsson, Lif, the research-based pharmaceutical industry Jolanta Gulbinovič, Vilnius University Niklas Hedberg, The Dental and Pharmaceutical Benefits Agency, EUnetHTA Trine Ann Behnk, Amgros I/S Hanna Rickberg, Läkemedelsakademin